Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis
Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis
Recruiting · NCT06867991 · Registry updated 2026-06-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis | Neoplasms by Site, Neuroinflammatory Diseases, Paraneoplastic Syndromes, Nervous System, anti-NMDA receptor encephalitis, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, central nervous system disorder, encephalitis, immune system disorder, neoplasm, nervous system disorder, neurodegenerative disease, paraneoplastic syndrome | Recruiting | Phase 3 | 2026-06-09 | NCT06867991 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The First People's Hospital of Changzhou | 35 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 56 |
| The First People's Hospital of Changzhou | Changzhou | China | 8 |